Loading…
Integrating cervical cancer and genital tract infection screening into mother, child health and family planning clinics in Eldoret, Kenya
Background: Visual inspection, with acetic acid (VIA) and with Lugol's iodine (VILI), has been demonstrated to have test characteristics comparable to those of Pap smear but are more affordable and easier implement. It also presents an opportunity for management of female genital tract infectio...
Saved in:
| Published in: | African health sciences 2010-03, Vol.10 (1), p.58-65 |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | |
|---|---|
| cites | |
| container_end_page | 65 |
| container_issue | 1 |
| container_start_page | 58 |
| container_title | African health sciences |
| container_volume | 10 |
| creator | Were, E Nyaberi, Z Buziba, N |
| description | Background: Visual inspection, with acetic acid (VIA) and with Lugol's
iodine (VILI), has been demonstrated to have test characteristics
comparable to those of Pap smear but are more affordable and easier
implement. It also presents an opportunity for management of female
genital tract infection. Objectives: Pilot test integration of cervical
cancer screening using visual inspection with genital tract infection
identification into an existing MCH-FP in MTRH. Methods: Cross
sectional, descriptive study in which consecutive women were screened
for genital tract inflammatory morbidity and cervical cancer through
visual inspection. Results: Two hundred and nineteen women with a mean
age of 31.3years, parity of 3.1 were screened. About 54% of study
participants had multiple sex partners, 62% had sexual debut earlier
than 20 years, while use of tobacco was reported by 4%. The test
positivity rate was 13.9% and 16.9% for VIA and VILI respectively.
Positive test finding was significantly related to contraceptive
never-use after controlling for previous screening (p=0.006). Symptoms
of genital tract infections were reported by 38% of the participants
with features of cervicitis being reported by nearly 24%. Conclusion:
Integration of cervical cancer screening and genital tract infection
identification and treatment into the existing MCH-FP appears feasible. |
| format | article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2895794</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2586787277</sourcerecordid><originalsourceid>FETCH-LOGICAL-b332t-2aa1d84cf9e91a1c71ca4851af57f9361bb086567e1483197a3d194f8e4263e53</originalsourceid><addsrcrecordid>eNpdkcuKFTEQhhtRnHH0FSTgws205NK5bQQZRh0ccKPrpjpdfTpDOjkmOQPnEXxrw9xQIZCi6vt_6k-edadMc9tTScXzVitDe2WpPOlelXJDKVfMspfdCaeGMcnVaff7KlbcZag-7ojDfOsdBOIgtppAnMkOo6-tVTO4Snxc0FWfIikuYxs1lY81kS3VFfM5casPM1kRQl3v9AtsPhzJPkC8o13w0bvSVOQyzCljPSffMB7hdfdigVDwzcN91v38fPnj4mt__f3L1cWn634SgteeA7DZDG6xaBkwp5mDwUgGi9SLFYpNEzVKKo1sMIJZDWJmdlgMDlwJlOKs-3jvuz9MG84OY4sWxn32G-TjmMCP_06iX8dduh25sVLboRm8fzDI6dcBSx03XxyGlhDToYxaCmuVMqyR7_4jb9Ihx5Zu5NIobTTXulFv_17oaZPHT2rAh3tg8qm9Hj4RLnsYH5traYdRypj4AwDBohM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2586787277</pqid></control><display><type>article</type><title>Integrating cervical cancer and genital tract infection screening into mother, child health and family planning clinics in Eldoret, Kenya</title><source>Open Access: PubMed Central</source><creator>Were, E ; Nyaberi, Z ; Buziba, N</creator><creatorcontrib>Were, E ; Nyaberi, Z ; Buziba, N</creatorcontrib><description>Background: Visual inspection, with acetic acid (VIA) and with Lugol's
iodine (VILI), has been demonstrated to have test characteristics
comparable to those of Pap smear but are more affordable and easier
implement. It also presents an opportunity for management of female
genital tract infection. Objectives: Pilot test integration of cervical
cancer screening using visual inspection with genital tract infection
identification into an existing MCH-FP in MTRH. Methods: Cross
sectional, descriptive study in which consecutive women were screened
for genital tract inflammatory morbidity and cervical cancer through
visual inspection. Results: Two hundred and nineteen women with a mean
age of 31.3years, parity of 3.1 were screened. About 54% of study
participants had multiple sex partners, 62% had sexual debut earlier
than 20 years, while use of tobacco was reported by 4%. The test
positivity rate was 13.9% and 16.9% for VIA and VILI respectively.
Positive test finding was significantly related to contraceptive
never-use after controlling for previous screening (p=0.006). Symptoms
of genital tract infections were reported by 38% of the participants
with features of cervicitis being reported by nearly 24%. Conclusion:
Integration of cervical cancer screening and genital tract infection
identification and treatment into the existing MCH-FP appears feasible.</description><identifier>ISSN: 1680-6905</identifier><identifier>EISSN: 1729-0503</identifier><identifier>PMID: 20811526</identifier><language>eng</language><publisher>Uganda: Makerere University Medical School</publisher><subject><![CDATA[Adult ; African studies ; Age Factors ; Cervical cancer ; Cervical Intraepithelial Neoplasia - diagnosis ; Cervical Intraepithelial Neoplasia - prevention & control ; Child ; Cross-Sectional Studies ; Delivery of Health Care, Integrated - organization & administration ; Family Planning Services - organization & administration ; Female ; Genital Diseases, Female - diagnosis ; Genital Diseases, Female - epidemiology ; Genital Diseases, Female - prevention & control ; Health and Medicine ; Humans ; Infections ; Inspections ; Kenya - epidemiology ; Kenyans ; Mass Screening - utilization ; Maternal-Child Health Centers - organization & administration ; Medical research ; Original ; Pilot Projects ; Risk Factors ; Uterine Cervical Neoplasms - diagnosis ; Uterine Cervical Neoplasms - epidemiology ; Uterine Cervical Neoplasms - prevention & control ; Womens studies ; Young Adult]]></subject><ispartof>African health sciences, 2010-03, Vol.10 (1), p.58-65</ispartof><rights>Copyright 2010 - Makerere Medical School, Uganda</rights><rights>Copyright © Makerere Medical School, Uganda 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895794/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895794/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20811526$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Were, E</creatorcontrib><creatorcontrib>Nyaberi, Z</creatorcontrib><creatorcontrib>Buziba, N</creatorcontrib><title>Integrating cervical cancer and genital tract infection screening into mother, child health and family planning clinics in Eldoret, Kenya</title><title>African health sciences</title><addtitle>Afr Health Sci</addtitle><description>Background: Visual inspection, with acetic acid (VIA) and with Lugol's
iodine (VILI), has been demonstrated to have test characteristics
comparable to those of Pap smear but are more affordable and easier
implement. It also presents an opportunity for management of female
genital tract infection. Objectives: Pilot test integration of cervical
cancer screening using visual inspection with genital tract infection
identification into an existing MCH-FP in MTRH. Methods: Cross
sectional, descriptive study in which consecutive women were screened
for genital tract inflammatory morbidity and cervical cancer through
visual inspection. Results: Two hundred and nineteen women with a mean
age of 31.3years, parity of 3.1 were screened. About 54% of study
participants had multiple sex partners, 62% had sexual debut earlier
than 20 years, while use of tobacco was reported by 4%. The test
positivity rate was 13.9% and 16.9% for VIA and VILI respectively.
Positive test finding was significantly related to contraceptive
never-use after controlling for previous screening (p=0.006). Symptoms
of genital tract infections were reported by 38% of the participants
with features of cervicitis being reported by nearly 24%. Conclusion:
Integration of cervical cancer screening and genital tract infection
identification and treatment into the existing MCH-FP appears feasible.</description><subject>Adult</subject><subject>African studies</subject><subject>Age Factors</subject><subject>Cervical cancer</subject><subject>Cervical Intraepithelial Neoplasia - diagnosis</subject><subject>Cervical Intraepithelial Neoplasia - prevention & control</subject><subject>Child</subject><subject>Cross-Sectional Studies</subject><subject>Delivery of Health Care, Integrated - organization & administration</subject><subject>Family Planning Services - organization & administration</subject><subject>Female</subject><subject>Genital Diseases, Female - diagnosis</subject><subject>Genital Diseases, Female - epidemiology</subject><subject>Genital Diseases, Female - prevention & control</subject><subject>Health and Medicine</subject><subject>Humans</subject><subject>Infections</subject><subject>Inspections</subject><subject>Kenya - epidemiology</subject><subject>Kenyans</subject><subject>Mass Screening - utilization</subject><subject>Maternal-Child Health Centers - organization & administration</subject><subject>Medical research</subject><subject>Original</subject><subject>Pilot Projects</subject><subject>Risk Factors</subject><subject>Uterine Cervical Neoplasms - diagnosis</subject><subject>Uterine Cervical Neoplasms - epidemiology</subject><subject>Uterine Cervical Neoplasms - prevention & control</subject><subject>Womens studies</subject><subject>Young Adult</subject><issn>1680-6905</issn><issn>1729-0503</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNpdkcuKFTEQhhtRnHH0FSTgws205NK5bQQZRh0ccKPrpjpdfTpDOjkmOQPnEXxrw9xQIZCi6vt_6k-edadMc9tTScXzVitDe2WpPOlelXJDKVfMspfdCaeGMcnVaff7KlbcZag-7ojDfOsdBOIgtppAnMkOo6-tVTO4Snxc0FWfIikuYxs1lY81kS3VFfM5casPM1kRQl3v9AtsPhzJPkC8o13w0bvSVOQyzCljPSffMB7hdfdigVDwzcN91v38fPnj4mt__f3L1cWn634SgteeA7DZDG6xaBkwp5mDwUgGi9SLFYpNEzVKKo1sMIJZDWJmdlgMDlwJlOKs-3jvuz9MG84OY4sWxn32G-TjmMCP_06iX8dduh25sVLboRm8fzDI6dcBSx03XxyGlhDToYxaCmuVMqyR7_4jb9Ihx5Zu5NIobTTXulFv_17oaZPHT2rAh3tg8qm9Hj4RLnsYH5traYdRypj4AwDBohM</recordid><startdate>20100301</startdate><enddate>20100301</enddate><creator>Were, E</creator><creator>Nyaberi, Z</creator><creator>Buziba, N</creator><general>Makerere University Medical School</general><general>Makerere Medical School</general><scope>RBI</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20100301</creationdate><title>Integrating cervical cancer and genital tract infection screening into mother, child health and family planning clinics in Eldoret, Kenya</title><author>Were, E ; Nyaberi, Z ; Buziba, N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b332t-2aa1d84cf9e91a1c71ca4851af57f9361bb086567e1483197a3d194f8e4263e53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adult</topic><topic>African studies</topic><topic>Age Factors</topic><topic>Cervical cancer</topic><topic>Cervical Intraepithelial Neoplasia - diagnosis</topic><topic>Cervical Intraepithelial Neoplasia - prevention & control</topic><topic>Child</topic><topic>Cross-Sectional Studies</topic><topic>Delivery of Health Care, Integrated - organization & administration</topic><topic>Family Planning Services - organization & administration</topic><topic>Female</topic><topic>Genital Diseases, Female - diagnosis</topic><topic>Genital Diseases, Female - epidemiology</topic><topic>Genital Diseases, Female - prevention & control</topic><topic>Health and Medicine</topic><topic>Humans</topic><topic>Infections</topic><topic>Inspections</topic><topic>Kenya - epidemiology</topic><topic>Kenyans</topic><topic>Mass Screening - utilization</topic><topic>Maternal-Child Health Centers - organization & administration</topic><topic>Medical research</topic><topic>Original</topic><topic>Pilot Projects</topic><topic>Risk Factors</topic><topic>Uterine Cervical Neoplasms - diagnosis</topic><topic>Uterine Cervical Neoplasms - epidemiology</topic><topic>Uterine Cervical Neoplasms - prevention & control</topic><topic>Womens studies</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Were, E</creatorcontrib><creatorcontrib>Nyaberi, Z</creatorcontrib><creatorcontrib>Buziba, N</creatorcontrib><collection>Bioline International</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>African health sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Were, E</au><au>Nyaberi, Z</au><au>Buziba, N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Integrating cervical cancer and genital tract infection screening into mother, child health and family planning clinics in Eldoret, Kenya</atitle><jtitle>African health sciences</jtitle><addtitle>Afr Health Sci</addtitle><date>2010-03-01</date><risdate>2010</risdate><volume>10</volume><issue>1</issue><spage>58</spage><epage>65</epage><pages>58-65</pages><issn>1680-6905</issn><eissn>1729-0503</eissn><abstract>Background: Visual inspection, with acetic acid (VIA) and with Lugol's
iodine (VILI), has been demonstrated to have test characteristics
comparable to those of Pap smear but are more affordable and easier
implement. It also presents an opportunity for management of female
genital tract infection. Objectives: Pilot test integration of cervical
cancer screening using visual inspection with genital tract infection
identification into an existing MCH-FP in MTRH. Methods: Cross
sectional, descriptive study in which consecutive women were screened
for genital tract inflammatory morbidity and cervical cancer through
visual inspection. Results: Two hundred and nineteen women with a mean
age of 31.3years, parity of 3.1 were screened. About 54% of study
participants had multiple sex partners, 62% had sexual debut earlier
than 20 years, while use of tobacco was reported by 4%. The test
positivity rate was 13.9% and 16.9% for VIA and VILI respectively.
Positive test finding was significantly related to contraceptive
never-use after controlling for previous screening (p=0.006). Symptoms
of genital tract infections were reported by 38% of the participants
with features of cervicitis being reported by nearly 24%. Conclusion:
Integration of cervical cancer screening and genital tract infection
identification and treatment into the existing MCH-FP appears feasible.</abstract><cop>Uganda</cop><pub>Makerere University Medical School</pub><pmid>20811526</pmid><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1680-6905 |
| ispartof | African health sciences, 2010-03, Vol.10 (1), p.58-65 |
| issn | 1680-6905 1729-0503 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2895794 |
| source | Open Access: PubMed Central |
| subjects | Adult African studies Age Factors Cervical cancer Cervical Intraepithelial Neoplasia - diagnosis Cervical Intraepithelial Neoplasia - prevention & control Child Cross-Sectional Studies Delivery of Health Care, Integrated - organization & administration Family Planning Services - organization & administration Female Genital Diseases, Female - diagnosis Genital Diseases, Female - epidemiology Genital Diseases, Female - prevention & control Health and Medicine Humans Infections Inspections Kenya - epidemiology Kenyans Mass Screening - utilization Maternal-Child Health Centers - organization & administration Medical research Original Pilot Projects Risk Factors Uterine Cervical Neoplasms - diagnosis Uterine Cervical Neoplasms - epidemiology Uterine Cervical Neoplasms - prevention & control Womens studies Young Adult |
| title | Integrating cervical cancer and genital tract infection screening into mother, child health and family planning clinics in Eldoret, Kenya |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T18%3A34%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Integrating%20cervical%20cancer%20and%20genital%20tract%20infection%20screening%20into%20mother,%20child%20health%20and%20family%20planning%20clinics%20in%20Eldoret,%20Kenya&rft.jtitle=African%20health%20sciences&rft.au=Were,%20E&rft.date=2010-03-01&rft.volume=10&rft.issue=1&rft.spage=58&rft.epage=65&rft.pages=58-65&rft.issn=1680-6905&rft.eissn=1729-0503&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E2586787277%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b332t-2aa1d84cf9e91a1c71ca4851af57f9361bb086567e1483197a3d194f8e4263e53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2586787277&rft_id=info:pmid/20811526&rfr_iscdi=true |